Government advisers determined that the benefits of the Pfizer-BioNTech vaccine is safe and effective, clearing the way for final FDA approval of the shot this week.
The agency is expected to introduce new, tougher standards to get emergency approval for the vaccine in an effort to boost public confidence.
The Trump administration wants states to be ready to distribute a coronavirus vaccine two days before the presidential election.